Archives

IperionX Limited (IPX) has received a substantial holder notice dated 21 July 2026 indicating that State Street Corporation and its subsidiaries, along with associated institutional investors, have increased their combined voting power in the company to 6.71%. The change represents an increase from the previous notice dated 25 May 2026, which disclosed 5.66% voting power. The updated shareholding reflects various investment management arrangements held through State Street Global Advisors entities, State Street Bank and Trust Company, and multiple pension and retirement funds including the University of California, the State of Alaska Retirement Management Board, and New Jersey's Police and Firemens Retirement System.

• July 21, 2026 05:21 PM AEST
• Aakashdeep

Vertex Minerals Limited (ASX: VTX) has lodged corrected director interest notices to fix a typographical error in previously filed disclosures. Director Tully Richards' VTXO listed options expire on 17 July 2027, not 7 July 2027 as originally reported. The company, which operates in the minerals exploration sector, made the correction public on 21 July 2026 following the initial misfiled notices from 5 June 2026.

• July 21, 2026 05:21 PM AEST
• Anjali Anand

Algorae Pharmaceuticals Limited (1AI) has lodged a Final Director's Interest Notice confirming that Bradley John Dilkes ceased his role as director on 14 July 2026. The notice discloses Dilkes' shareholding position at the time of departure, comprising direct and indirect interests in the company's fully paid ordinary shares. This regulatory filing marks the formal conclusion of Dilkes' directorship and provides investors with a complete record of his securities holdings as at the cessation date.

• July 21, 2026 05:21 PM AEST
• Manish Choudhary

Ceretas Limited has progressed toward official ASX listing under the ticker CTS, confirming completion of intellectual property asset assignment and establishing employee incentive arrangements ahead of quotation. The Brisbane-based company has secured ASX waivers permitting performance rights with below-standard exercise pricing and disclosed restricted securities subject to escrow arrangements. The company update details governance compliance, shareholder distribution, and incentive structures designed to align management with shareholder interests during its market debut.

• July 21, 2026 05:13 PM AEST
• Aakashdeep

Enterprise Metals Limited (ENT) has notified the ASX that 156,096,319 unquoted options expired without exercise on 19 July 2026. The options, which carried an exercise price of $0.006, were part of the company's issued capital structure. The expiry represents a material reduction in the company's outstanding convertible securities and marks a scheduled maturity of a component of Enterprise Metals' capital management framework.

• July 21, 2026 05:13 PM AEST
• Shwetambri Chauhan

ECS Botanics Holdings Ltd (ASX: ECS), an Australian medicinal cannabis cultivator and manufacturer, has announced a live streamed investor webinar scheduled for Tuesday 28 July 2026 at 1:00pm AEST. The presentation will feature Managing Director Nan-Maree Schoerie discussing the company's June 2026 quarterly report and operational performance. Shareholders, investors and brokers are invited to participate in the live session, with the opportunity to submit questions and access a recorded version following completion.

• July 21, 2026 05:13 PM AEST
• Shwetambri Chauhan

Spheria Emerging Companies Limited (SEC) has announced an ordinary dividend of AUD 0.011 per share, fully franked at the company tax rate of 30 per cent. The distribution relates to the one-month period ending 30 June 2026, with an ex-date of 24 July 2026 and payment scheduled for 31 July 2026. The announcement signals the company's continued dividend distribution policy to shareholders in its emerging companies investment portfolio.

• July 21, 2026 05:09 PM AEST
• Aditi Sarkar

Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE), a clinical-stage biotechnology company developing disease-modifying treatments for neurodegenerative diseases, announced that Chief Executive Officer Dr. David Stamler will participate in the virtual BTIG Biotechnology Conference 2026 on 28–29 July 2026. The company will conduct one-on-one investor meetings during the conference, providing an opportunity to discuss its lead asset ATH434 and advancement toward a Phase 3 pivotal trial in Multiple System Atrophy (MSA).

• July 21, 2026 05:04 PM AEST
• Anjali Anand

Perpetual Equity Investment Company Limited (ASX: PIC) has announced its Net Tangible Asset (NTA) backing per ordinary share as at 20 July 2026, providing investors with an update on the company's investment portfolio valuation. The company reported NTA before tax of $1.175 per share and NTA after tax of $1.174 per share, representing the unaudited approximate value of the fund's assets on that date. This regular disclosure is a key metric for closed-end investment companies, allowing shareholders to assess the underlying value of their holdings relative to any share price premium or discount.

• July 21, 2026 05:04 PM AEST
• Shwetambri Chauhan

Ceretas Limited (ASX: CTS) has established a formal Securities Trading Policy designed to prevent insider trading and ensure compliance with the Corporations Act 2001 (Cth). The policy applies to all directors, officers, employees, contractors and consultants of the company and establishes strict protocols around when company securities can be traded. The framework introduces designated closed periods aligned with financial reporting cycles and requires prior written clearance from designated approving officers before any trading can occur.

• July 21, 2026 05:04 PM AEST
• Sonal Goyal